Cephalexin Uses and Dosing Guidelines
Cephalexin is a first-generation oral cephalosporin antibiotic primarily used to treat skin and soft tissue infections, respiratory tract infections, urinary tract infections, and bone infections caused by methicillin-susceptible Staphylococcus aureus (MSSA) and Streptococcus species. 1
Primary Clinical Indications
Skin and Soft Tissue Infections
- The standard adult dose is 500 mg orally every 6 hours (four times daily) for MSSA skin infections, as recommended by the Infectious Diseases Society of America 2, 3
- For surgical site infections following clean procedures (trunk or extremity surgery away from axilla/perineum), cephalexin 500 mg every 6 hours orally is an appropriate option 2
- Cephalexin achieves cure rates of 90% or higher for streptococcal and staphylococcal skin infections 4
- Treatment duration is typically 7-10 days depending on clinical response 3, 5
Respiratory Tract Infections
- For streptococcal pharyngitis and tonsillitis, cephalexin is comparable to penicillin in efficacy 6
- Adult dosing: 500 mg every 12 hours for streptococcal pharyngitis 1
- Critical limitation: Cephalexin has poor activity against Haemophilus influenzae, making it inappropriate for sinusitis, many community-acquired pneumonias, and otitis media where H. influenzae is suspected 7, 6, 3
- For beta-hemolytic streptococcal infections, treatment must continue for at least 10 days to prevent rheumatic fever 1, 3
Urinary Tract Infections
- For uncomplicated cystitis in patients over 15 years: 500 mg every 12 hours for 7-14 days 1
- Cephalexin achieves urinary concentrations of 500-1000 mcg/mL following 250-500 mg oral doses, far exceeding minimum inhibitory concentrations for common uropathogens 8
- Single-dose therapy (3 g) shows 67% cure rates for acute uncomplicated UTIs, though this is not standard practice 9
Dosing by Patient Population
Adult Dosing
- Standard range: 1-4 grams daily in divided doses 1
- Usual dose: 250 mg every 6 hours for mild infections 1
- For moderate-to-severe infections: 500 mg every 6 hours 1, 3
- If doses exceeding 4 grams daily are required, switch to parenteral cephalosporins (e.g., cefazolin 1 g IV every 8 hours) 10
Pediatric Dosing
- Standard: 25-50 mg/kg/day divided into 4 doses for mild-to-moderate infections 1, 3
- For MSSA infections: 75-100 mg/kg/day divided into 3-4 doses 3, 10
- For otitis media: 75-100 mg/kg/day in 4 divided doses is required 1
- For streptococcal pharyngitis and skin infections in children over 1 year, the total daily dose may be divided every 12 hours 1
Renal Impairment
- Patients with creatinine clearance <30 mL/min require dose reduction proportional to reduced renal function 8
Antimicrobial Spectrum and Critical Limitations
Effective Coverage
- Methicillin-susceptible Staphylococcus aureus (MSSA) 3, 10, 4
- Streptococcus pyogenes (Group A Streptococcus) 6, 4
- Other beta-hemolytic streptococci 1, 6
Critical Coverage Gaps (Common Pitfalls)
- Completely ineffective against MRSA - if MRSA is suspected, use trimethoprim-sulfamethoxazole, doxycycline, or clindamycin instead 10, 5, 3
- Poor activity against Haemophilus influenzae - do not use for sinusitis, otitis media, or respiratory infections where H. influenzae is likely 7, 6, 3
- Inadequate against Moraxella catarrhalis (beta-lactamase producing strains) 3
- No activity against Pseudomonas aeruginosa 3
- Limited anaerobic coverage - unsuitable for deep abscesses or infections requiring anaerobic coverage 10
- Poor coverage for Pasteurella multocida (animal bites) and Eikenella corrodens (human bites) 10
- High resistance rates (96%) among viridans group streptococci - not recommended for endocarditis prophylaxis 3
Special Clinical Considerations
Penicillin Allergy
- Cephalexin can be used in patients with non-severe penicillin allergy (non-IgE mediated reactions) 10, 5
- Contraindicated in patients with history of anaphylaxis, angioedema, or urticaria to penicillins due to potential cross-reactivity 3, 5
Pregnancy and Lactation
- For lactating women with mastitis: 500 mg orally every 6 hours 3
- Cephalexin achieves therapeutic levels in breast milk (0.09-0.59 mcg/mL in healthy milk; 0.57-1.05 mcg/mL in infected milk) and is considered safe for nursing infants 3
Administration and Storage
- Cephalexin is absorbed in the upper intestine, not the stomach, ensuring reliable bioavailability 8
- Does not disturb lower bowel flora due to absorption high in the intestinal tract 8
- Suspension must be refrigerated after mixing and remains stable for 14 days 1
Algorithm for Appropriate Use
Step 1: Identify the infection type and likely pathogens
- Skin/soft tissue with suspected MSSA/Streptococcus → Cephalexin appropriate
- Respiratory infection with possible H. influenzae → Choose alternative agent
- Suspected MRSA → Choose alternative agent (TMP-SMX, doxycycline, clindamycin)
Step 2: Assess patient factors
- Penicillin allergy history: severe (anaphylaxis/angioedema) → avoid cephalexin; non-severe → cephalexin acceptable
- Renal function: CrCl <30 mL/min → reduce dose proportionally
Step 3: Select appropriate dose
- Adults: 500 mg every 6 hours for most infections
- Children: 25-50 mg/kg/day (mild) or 75-100 mg/kg/day (MSSA) in divided doses
- Duration: 7-10 days (minimum 10 days for streptococcal infections)
Step 4: Monitor for treatment failure
- If no improvement by day 5, consider MRSA, resistant organisms, or alternative diagnosis 5